The presence of circulating tumor DNA (ctDNA) at end of treatment (EOT) was shown to be prognostic of event-free survival (EFS) outcomes for patients with lymphoma regardless of subtype, according to findings from a retrospective, real-world…
Category: 6. Business
-
3 Things You Should Do Before 2026.
-
Buffett has been selling stocks and building up a record level of cash for several quarters.
-
His moves may inspire us to take valuable steps now that could support the long-term growth of our portfolios.
-
10 stocks we like better than…
Continue Reading
-
-
SpaceX to offer insider shares at record-setting $800 billion valuation
SpaceX is preparing to sell insider shares in a transaction that would value Elon Musk’s rocket and satellite maker at as much as $800 billion, people familiar with the matter said, reclaiming the title of the world’s most valuable private…
Continue Reading
-
Assessing Valuation After a Recent Pullback in the Share Price
CSG Systems International (CSGS) has quietly delivered strong long term returns, and its recent pullback could catch the eye of investors looking for steady growth in communications software and services.
See our latest analysis for CSG…
Continue Reading
-
Should Expeditors’ Rising Role in AI-Driven Logistics Require Action From Expeditors International (EXPD) Investors?
-
In recent days, Expeditors International of Washington was highlighted by BofA for stronger-than-expected demand in customs and airfreight, alongside growth in export airfreight tonnage from North and South Asia and deeper penetration into…
Continue Reading
-
-
Does Jamf’s Sluggish Share Price Hide Long Term Value Potential in 2025?
-
Wondering if Jamf Holding at around $12.97 is quietly setting up a value opportunity, or if the market is signaling you should stay cautious? This breakdown is designed to help you decide with confidence.
-
While the stock is roughly flat…
Continue Reading
-
-
Musk denies $800 billion SpaceX valuation reports
Elon Musk attends the U.S.-Saudi Investment Forum in Washington, D.C., U.S., November 19, 2025.
Evelyn Hockstein | Reuters
Elon Musk on Saturday dismissed media reports that SpaceX is raising funds at an $800 billion valuation, calling them…
Continue Reading
-
Looking at the New Narrative for Nutanix After Its First Miss and Recalibrated Outlook
Nutanix’s fair value estimate has been cut from about $85.78 to $70.70 as analysts recalibrate expectations for the company in light of its latest quarter. With the discount rate nudging higher from roughly 8.66% to 8.79% and modeled revenue…
Continue Reading
-
Does Veolia Still Offer Upside After Strong Five Year Gains and DCF Implied Upside?
-
If you have been wondering whether Veolia Environnement is still a smart buy at around €29, you are not alone. This breakdown is aimed squarely at helping you decide if the current price makes sense.
-
The stock has been quietly grinding…
Continue Reading
-
